50 cancer types, one liquid biopsy: Exact Sciences' test enters market

Multi-cancer early detection tests have been available for years, yet many oncologists and researchers have been wary of recommending them.

September 12, 2025 Check out STAT+

Sponsored By

STAT turned 10 this week! Take a look back at 10 of our most impactful stories from the last decade and take advantage of a special anniversary STAT+ deal: 10 months for $10/month. Thanks for reading!

Exact Sciences STAT+ | Fifty cancer types in one liquid biopsy test: Exact Sciences enters early-detection market Liquid biopsy test Cancerguard can scan for 50 cancers in one blood sample. The company says it marks a new era in early detection, but there are caveats. By Angus Chen How the myth that nicotine causes cancer is hurting public health Misconceptions about nicotine and cancer keep smokers away from less-risky products, and nicotine-infused products are popping up in unexpected areas. By Sarah Todd Opinion: I created my own AI medical team. It changed the way doctors treat my cancer After being diagnosed with an aggressive form of blood cancer, I created my own virtual medical team. It showed what my doctors had missed. By Steve Brown Courtesy Michelle Patroni Opinion: The diagnosis that saved me — and may have misled my mother to her death The misdiagnosis that saved my life may influenced my mother's decision to delay radiation and chemotherapy. By Michelle Patroni STAT+ | Piercing the hype around Patrick Soon-Shiong's 'Bioshield' cancer treatment In this week's edition of "Adam's Biotech Scorecard," a closer look at the claims made recently by the biotech company ImmunityBio. By Adam Feuerstein STAT+ | Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look HHS Secretary Robert F. Kennedy Jr. plans to close what he calls a loophole that allows drugmakers to avoid sufficiently disclosing risk info By Ed Silverman Adobe Covid-19 falls off list of top 10 causes of death in U.S. New CDC data on leading causes of death reveal changing risks and troubling trends. Suicide enters top 10, heart disease and cancer remain first and second. By Elizabeth Cooney

More around STAT

---

In case you missed it A single exercise session may slow cancer cell growth, new study shows, Washington Post A promising new treatment for a tough cancer, STAT What the NHS can learn from the European country that helped more people survive cancer, BBC

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser